Publications：

(A) Journal Paper

• Kao W-H, Kuo C-F, Chou I-J, et al. Prostate-selective α antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: a nationwide population-based study. Oncotarget. 2018;9(4):5263-5273. doi:10.18632/oncotarget.23828 (SCI)
• Kao W-H, Hong J-H, See L-C, Yu H-P, Hsu J-T, Chou I-J, et al. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan. Pharmacoepidemiology and Drug Safety [Internet]. 2017 Aug 16 [cited 2017 Oct 13]; (SCI)
• Lin, S. Y., Tsai, C. S., Chang, Y. C., Ng, K. K., Chang, T. C., Kao, W. H., Lai, C. H., Hong, J. H. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up. International Journal of Radiation Oncology Biology Physics 2015; 92(3): 577-585 (SCI)
• Kao, W. H., Shen, Y. L., Hong, J. H. What are the Potential Benefits of Using Proton Therapy in Taiwanese Cancer Patients? Biomedical Journal 2015; (ahead of print)
• Kao, W. H., Hong, J. H., Chao, A. N. & Wang, J. J. Hypofractionated Stereotactic Photon Radiotherapy for Choroidal Melanoma. Therapeut Radiol Oncol 2014; 21(0): 1-10
  

(B) Conference Paper

• Kao, W. H., Chiang, Y. J., Hong, J. H., Wang, C. C. Birth Outcomes in Childbearing Age Female Cancer Survivors: A Nationwide Population-based Study. Poster presented at Europe Society for Radiation Oncology (ESTRO) 36th Annual Meeting, Vienna, May 05-07, 2017
  
• Kao, W. H., Lin, S.Y., Hong, J. H. & Tsai, J. S. A long-term Follow-up for a Prospective Randomized Trial Using Pretreatment FDG-PET in the Management of Cervical Cancer with Enlarged Pelvic Lymph Nodes on MRI image. Poster presented at the 18th Taiwan Joint Cancer Conference (TJCC), July 13~14, 2013
  
• Kao, W. H. & Wang, C. C. Whole Brain Radiotherapy with Simultaneously Integrated Boost for Patients with Multiple Brain Metastases by VMAT. Poster presented at American Society for Radiation Oncology (ASTRO) 55th Annual Meeting, Atlanta, Sept. 22-25, 2013